07:00 , Jun 16, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: HIF1A antisense RNA 2 (HIF1A-AS2)

Cancer INDICATION: Brain cancer Patient sample and mouse studies suggest inhibiting HIF1A-AS2 could help treat glioblastoma multiforme (GBM). In GBM patients, HIF1A-AS2 levels were higher in tumors than in adjacent normal brain tissue. In a mouse model...